Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoidosis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Sarcoidosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bottomicca, F; Camussi, G; Da Col, R; Libertucci, D; Scappaticci, E; Silvestro, L; Tetta, C1
Ishii, Y; Kitamura, S; Kobayashi, J1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoidosis

ArticleYear
Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis.
    The American review of respiratory disease, 1992, Volume: 146, Issue:2

    Topics: Adult; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Evaluation Studies as Topic; Female; Forced Expiratory Volume; Gallium Radioisotopes; Hospitals, University; Humans; Incidence; Italy; Lung Diseases; Lymphocytes; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; Platelet Activating Factor; Platelet Aggregation; Pulmonary Diffusing Capacity; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index; Vital Capacity

1992
[Roles of arachidonic acid cascade and related substances in respiratory diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9

    Topics: Animals; Arachidonic Acid; Asthma; Bronchi; Humans; Lung Diseases; Macrophages; Muscle Tonus; Platelet Activating Factor; Pulmonary Fibrosis; Respiratory Tract Diseases; Sarcoidosis; Smoking

1991